FindTrial
Sign In

Comparing effectiveness of Centchroman tablet versus evening primrose oil capsule for the pain relief in case of fibroadenosis breast.

Effectiveness of Centchroman versus evening primrose oil in the management of pain in fibroadenosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031228
Enrollment
50
Registered
2021-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: Tablet Centchroman: Tablet centchroman 30 mg twice weekly on monday and thursday morning after meals for 3 months Control Intervention1: Evening primrose oil capsule 1000 mg: Evening pr

Sponsors

Pondicherry Institute of Medical Sciences
Lead Sponsor
Pondicherry Institute of Medical Sciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Clinical findings: mastalgia

Exclusion criteria

Exclusion criteria: Pregnant women/Lactating women Patients who are planning to conceive Patient with previous history of DVT.

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of Tablet Centchroman versus Evening primrose oil capsule in the management of pain in fibroadenosis patients using visual analogue scale and mastalgia chartTimepoint: To compare the effectiveness of Tablet Centchroman versus Evening primrose oil capsule in the management of pain in fibroadenosis patients at the end of 4th week, 8th week and 12th week—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactSneha D V

Pondicherry institute of medical sciences

nirmal3106@gmail.com9944368936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026